Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma

被引:0
|
作者
Qi Weili [1 ]
Shen Junyi [2 ]
Zhang Yu [3 ]
Gao Fengwei [4 ]
Li Chuan [1 ]
机构
[1] Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China
[2] Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
[3] Organ Transplantation Center, Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
[4] HBPS Diseases Center for Diagnosis and Treatment of Leshan City, People’s Hospital of Leshan, Leshan, Sichuan,
关键词
D O I
暂无
中图分类号
R512.62 []; R735.7 [肝肿瘤];
学科分类号
摘要
<正>
引用
收藏
相关论文
共 50 条
  • [31] Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
    Su, Jia-Yong
    Wu, Ying-Ling
    Wu, Xuan-Lin
    Liu, Zhen-Xiu
    Wang, Yi-Yang
    Li, Zhong-Hai
    Luo, Jia-Xin
    Wu, Kun-Jun
    Zhong, Jian-Hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 842 - 844
  • [32] Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis
    Goyal S.K.
    Dixit V.K.
    Shukla S.K.
    Ghosh J.
    Behera M.
    Tripathi M.
    Gupta N.
    Ranjan A.
    Jain A.K.
    Indian Journal of Gastroenterology, 2015, 34 (4) : 286 - 291
  • [33] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence
    Yeh, Yi-Chun
    Chen, Pei-Jer
    Lai, Mei-Shu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 765 - 766
  • [34] ENTECAVIR VS. TENOFOVIR IN PREVENTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kamal, Faisal
    Khan, Muhammad Ali
    Marella, Hemnishil K.
    Bayoumi, Mahmoud
    Arshad, Hafiz Muhammad Sharjeel
    Mude, Pooja J.
    Waters, Bradford
    Nair, Satheesh
    GASTROENTEROLOGY, 2020, 158 (06) : S1289 - S1289
  • [35] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [36] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee
    Young Youn Cho
    Hyein Lee
    Jae Seung Lee
    Seung Up Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Beom Kyung Kim
    Soo Young Park
    Hepatology International, 2021, 15 : 1083 - 1092
  • [37] Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Kim, Hyeseung
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    GUT AND LIVER, 2016, 10 (06) : 939 - 947
  • [38] Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma
    Kubo, S
    Tsukamoto, T
    Kawai, S
    Hirohashi, K
    Tanaka, H
    Shuto, T
    Takemura, S
    Nishiguchi, S
    Kinoshita, H
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 497 - 499
  • [39] Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
    Lai, Ching-Lung
    Yuen, Man-Fung
    HEPATOLOGY, 2013, 57 (01) : 399 - 408
  • [40] Entecavir and Tenofovir More Effectively Reduce the Recurrence of Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Treatment than Low-potent Antivirals
    Ahn, Hongkeun
    Lee, Jeong-Hoon
    Chang, Young
    Nam, Joon Yeul
    Cho, Hyeki
    Cho, Young Youn
    Lee, Minjong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Donghyeon
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, June Sung
    HEPATOLOGY, 2015, 62 : 1191A - 1192A